These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18675569)

  • 1. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study.
    Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S
    Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study.
    López-Jornet P; Camacho-Alonso F; Leon-Espinosa S
    J Oral Rehabil; 2009 Jan; 36(1):52-7. PubMed ID: 18976257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies.
    Femiano F
    Minerva Stomatol; 2002 Sep; 51(9):405-9. PubMed ID: 12473978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trazodone in burning mouth pain: a placebo-controlled, double-blind study.
    Tammiala-Salonen T; Forssell H
    J Orofac Pain; 1999; 13(2):83-8. PubMed ID: 10425979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial.
    Cavalcanti DR; da Silveira FR
    J Oral Pathol Med; 2009 Mar; 38(3):254-61. PubMed ID: 19175713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth.
    Steele JC; Bruce AJ; Drage LA; Rogers RS
    Oral Dis; 2008 Sep; 14(6):529-32. PubMed ID: 18266840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burning mouth syndrome: the efficacy of lipoic acid on subgroups.
    Femiano F; Gombos F; Scully C
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):676-8. PubMed ID: 15482293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary protocol for systemic administration of capsaicin for the treatment of the burning mouth syndrome].
    Lauritano D; Petruzzi M; Baldoni M
    Minerva Stomatol; 2003 Jun; 52(6):273-8. PubMed ID: 12874531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative effect of lafutidine on oral burning sensation.
    Toida M; Kato K; Makita H; Long NK; Takeda T; Hatakeyama D; Yamashita T; Shibata T
    J Oral Pathol Med; 2009 Mar; 38(3):262-8. PubMed ID: 19175712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome.
    López-Jornet P; Camacho-Alonso F; Molino-Pagan D
    J Oral Pathol Med; 2013 Apr; 42(4):295-301. PubMed ID: 22957483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: a double-blind randomised.
    Cano-Carrillo P; Pons-Fuster A; López-Jornet P
    J Oral Rehabil; 2014 Apr; 41(4):296-305. PubMed ID: 24612248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial.
    López-D'alessandro E; Escovich L
    Med Oral Patol Oral Cir Bucal; 2011 Aug; 16(5):e635-40. PubMed ID: 20711135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of carpal tunnel syndrome with alpha-lipoic acid.
    Di Geronimo G; Caccese AF; Caruso L; Soldati A; Passaretti U
    Eur Rev Med Pharmacol Sci; 2009; 13(2):133-9. PubMed ID: 19499849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
    Danhauer SC; Miller CS; Rhodus NL; Carlson CR
    J Orofac Pain; 2002; 16(4):305-11. PubMed ID: 12455431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different therapeutic strategies for burning mouth syndrome: preliminary data.
    Marino R; Torretta S; Capaccio P; Pignataro L; Spadari F
    J Oral Pathol Med; 2010 Sep; 39(8):611-6. PubMed ID: 20701667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study on clonazepam in patients with burning mouth syndrome.
    Heckmann SM; Kirchner E; Grushka M; Wichmann MG; Hummel T
    Laryngoscope; 2012 Apr; 122(4):813-6. PubMed ID: 22344742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.
    Femiano F; Scully C
    J Oral Pathol Med; 2002 May; 31(5):267-9. PubMed ID: 12110042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.